Company · Ownership research

Revolution Medicines, Inc. RVMD

CIK 0001628171

Form 4 transactions dated Nov 1, 2023 to Nov 8, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 48 rows; the complete set is available through the API.

Insider filings on file run through Oct 28, 2026.

Insider purchases & sales

Purchased: $60.00M
Sold: $192.67M

Nov 1, 2023 – Oct 28, 2026
Available records · partial months are marked ·

202610 of 30 preview events · 48 available in 2026

Date	Insider	Activity	Trade value (USD)	% of prior holding
Oct 26, 2026	Mancini Anthony See Remarks	Sale10b5-1 footnote	$431.95K 2,310 shares sold	5.49% sold Direct holding	▾
Sep 29, 2026	Sandler Alan B. Chief Development Officer	Sale10b5-1 footnote	$1.28M 6,309 shares sold	10.72% sold Direct holding	▾
Sep 25, 2026	Cislini Jeff SVP & General Counsel	Sale10b5-1 footnote	$158.60K 765 shares sold	1.46% sold Direct holding	▾
Sep 25, 2026	Mancini Anthony See Remarks	Sale10b5-1 footnote	$625.89K 3,121 shares sold	7.28% sold Direct holding	▾
Sep 24, 2026	Mancini Anthony See Remarks	Sale10b5-1 footnote	$117.40K 587 shares sold	1.45% sold Direct holding	▾
Sep 22, 2026	ANDERSON ELIZABETH M Director	Sale10b5-1 footnote	$1.96M 10,143 shares sold	70.07% sold Direct holding	▾
Sep 18, 2026	Mancini Anthony See Remarks	Sale10b5-1 footnote	$347.40K 1,764 shares sold	4.19% sold Direct holding	▾
Sep 16, 2026	Mancini Anthony See Remarks	Sale10b5-1 footnote	$353.45K 1,774 shares sold	4.04% sold Direct holding	▾
Sep 16, 2026	Cislini Jeff SVP & General Counsel	Sale10b5-1 footnote	$670.63K 3,366 shares sold	6.02% sold Direct holding	▾
Sep 16, 2026	Sandler Alan B. Chief Development Officer	Sale10b5-1 footnote	$67.94K 341 shares sold	0.64% sold Direct holding	▾

Showing 30 / 48 record groups in 2026. The complete set is available through the API.

Revolution Medicines, Inc. · RVMD

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 48 purchase / sale groups and 30 of 80 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"RVMD","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.